Loading data for PRCT — first visit, this takes a few seconds.
PROCEPT BioRobotics Corporation
20.38 +0.31 (1.54%)
- Capitalisation boursière
- $1.16B
- Volume
- 1.57M
- Prochaine publication des résultats
- Nov 4, 2026
PROCEPT BioRobotics Corporation (PRCT) : cours, analyse et données
Valeur intrinsèque
Prévisions des analystes
Prévisions boursières →Derniers résultats
| Signalé | Écart estimé | Changement d’une année sur l’autre | |
|---|---|---|---|
| Chiffre d’affaires | $94.50M | n/a | +19.34% |
| EPS | -$0.47 | -$0.02 | -34.29% |
Métriques
- Cours acheteur
- 13.9
- Capitalisation boursière
- 1.16B
- Résultat net (ttm)
- -110M
- 0.90
- -1.95
- n/a
- -17.68
- P/B (ttm)
- 3.43
- P/S (ttm)
- 3.46
- Date des résultats
- Nov 4, 2026
- Cours vendeur
- 22.04
- Volume
- 1,573,244
- Volume moy. (20D)
- 1,582,977
- Ouverture
- 20.53
- Clôture précédente
- 20.07
- Fourchette du jour
- 19.55 - 20.67
- Intervalle de 52 semaines
- 16.66 - 40.10
- Analyste
- n/a
- Objectif de prix
- n/a
- Dividendes
- n/a
- Date ex-dividende
- n/a
À propos de PROCEPT BioRobotics Corporation
Voir le profil →PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology in the United States and internationally. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery focusing on treating benign prostatic hyperplasia. The company also provides HYDROS Robotic System, which provides Aquablation therapy image-guided robotic therapy to treat males suffering from lower urinary tract symptoms due to benign prostatic hyperplasia. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.
PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology in the United States and internationally. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery focusing on treating benign prostatic hyperplasia. The company also provides HYDROS Robotic System, which provides Aquablation therapy image-guided robotic therapy to treat males suffering from lower urinary tract symptoms due to benign prostatic hyperplasia. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.
Industrie Medical Devices
Secteur Healthcare
Date d’introduction Sep 15, 2021
Employés 888
Bourse NasdaqGM
Symbole boursier PRCT
Site web https://www.procept-biorobotics.com